Monica Gianoli

Dr. Monica Gianoli

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2022 in IJC Heart & Vasculature
Verified
Journal Article
Open access
MGMonica Gianoli
Monica Gianoli
AJAnne R. de Jong
Anne R. de Jong
KJKirolos A. Jacob
Kirolos A. Jacob
HNHanae F. Namba
Hanae F. Namba
NKNiels P. van der Kaaij
Niels P. van der Kaaij
WSWillem J.L Suyker
Willem J.L Suyker
Minimally invasive direct coronary artery bypass (MIDCAB) surgery and percutaneous coronary intervention (PCI) are both well-established minimally invasive revascularization strategies in patients with proximal left anterior descending (LAD) lesions. We aimed to evaluate the 20-years’ experience by performing a systematic review and meta-analysis comparing MIDCAB versus PCI in adults with proximal LAD disease. We searched MEDLINE, EMBASE and Cochrane on October 1st, 2021 for articles published in the year 2000 or later. The primary outcome was all-cause mortality. Secondary outcomes included cardiac mortality, repeat target vessel revascularization (rTVR), myocardial infarction (MI), and cerebrovascular accident (CVA). Outcomes were analysed at short-term, mid-term, and long-term follow-up. Random effects meta-analyses were performed. Events were compared using risk ratios (RR) with 95% confidence intervals (CI). Our search yielded 17 studies pooling 3847 patients. At short-term follow-up, cardiac mortality was higher with MIDCAB than with PCI (RR 7.30, 95% CI: 1.38 to 38.61). At long-term follow-up, MIDCAB showed a decrease in all-cause mortality (RR 0.66, 95% CI: 0.46 to 0.93). MIDCAB showed a decrease in rTVR at mid-term follow-up (RR 0.16, 95% CI: 0.11 to 0.23) and at long-term follow-up (RR 0.25, 95% CI: 0.17 to 0.38). MI and CVA comparisons were not significant. In conclusion, in patients with proximal LAD lesions, MIDCAB showed a higher short-term mortality in the RCTs, but the cohort studies suggested a lower all-cause mortality at long-term follow-up. We confirm a decreased rTVR at mid-term follow-up in the RCTs and long-term follow-up in the cohort studies.

1 July 2024 in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Verified
Journal Article
Open access
MGMonica Gianoli
Monica Gianoli
AJAnne R. de Jong
Anne R. de Jong
PHPim van der Harst
Pim van der Harst
NKNiels P. van der Kaaij
Niels P. van der Kaaij
KJKirolos A. Jacob
Kirolos A. Jacob
WSWillem J. L. Suyker
Willem J. L. Suyker
Objective: Throughout Europe, the interest in implementing robot-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB) has been growing. However, concerns about additional costs have emerged concurrently. In this analysis, we aim to provide a comparison of the cumulative perioperative costs of RA-MIDCAB, on-pump coronary artery bypass grafting (CABG), and off-pump CABG (OPCAB). Methods: We conducted a propensity score–matched analysis comparing patients undergoing RA-MIDCAB with those undergoing CABG or OPCAB at our institution from January 2016 to December 2021. After matching, we analyzed the combined intraoperative surgical costs and 30-day postoperative costs. We first compared RA-MIDCAB costs to CABG and then to OPCAB separately. Violin plots illustrated the cost distribution among individual patients. Total cost uncertainty was estimated using 1,000 bootstrapping iterations. Results: Seventy-nine RA-MIDCAB patients were matched to 158 CABG patients, and 80 RA-MIDCAB patients were matched to 149 OPCAB patients. Considering both surgical and clinical outcomes, RA-MIDCAB yielded an average cost of €17,121 per patient (€16,781 to €33,294), CABG was €16,571 per patient (€16,664 to €41,860), and OPCAB was €15,463 per patient (€10,895 to €57,867). After bootstrap iterations, RA-MIDCAB was found to be €472 (2.8%) and €1,599 (10.3%) more expensive per patient than CABG and OPCAB, respectively. Conclusions: In The Netherlands, the adoption of RA-MIDCAB did not show a significant economic impact on hospital resources. The additional robotic costs for the surgery were almost entirely offset by the cost savings during the postoperative hospital stay. However, these comparisons may differ when considering hybrid coronary revascularization with its additional percutaneous coronary intervention costs.

1 October 2024 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
WOWouter Oosterlinck
Wouter Oosterlinck
MGMonica Gianoli
Monica Gianoli
Meindert PalmenMeindert Palmen
Meindert Palmen
TFThierry Folliguet
Thierry Folliguet
JBJohannes Bonatti
Johannes Bonatti
SCStepan Cerny
Stepan Cerny
The implementation of robotic surgical systems has reduced the invasive nature of certain cardiac surgical procedures over the recent decades. In the early days, coronary artery bypass grafting (CABG) and mitral valve repair (MVR) were mostly performed through a conventional sternotomy approach. Over time, however, minimally invasive techniques, including endoscopic methods, have become routine, particularly for MVR and MIDCAB procedures. The introduction of robotic surgical systems in the 1990s further advanced these techniques, offering valuable opportunities for continued innovation. This evolution is also closely linked with Enhanced Recovery After Cardiac Surgery (ERACS) and other related concepts that have become integral to modern cardiac surgery. However, technical, logistic and cost-related issues, related to the robotic platform, have hampered and slowed down the widespread adoption of the robotic CABG procedure [ 1]. Innovations and especially technical ones do not emerge gradually and constantly but come in waves. In the beginning, innovations are almost always cumbersome, unreliable, expensive and without any convenient infrastructure, e.g. printing press, electricity, railroads, cars, computers. The dissemination of innovations is therefore costly, slow, risky and entails drastic changes in behaviour [ 2]. After many decades, the introduction of an innovation may look perfectly smooth and easy. However, every innovation must fight against existing interests, established knowledge and those who staunchly defend both. Fear and mistrust of everything new and different are endemic.

1 July 2024 in Annals of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
MGMonica Gianoli
Monica Gianoli
KJKirolos A. Jacob
Kirolos A. Jacob
WSWillem J. L. Suyker
Willem J. L. Suyker
Background: The difficulty of suturing perfect anastomoses in limited-access conditions prevents the transition of traditional coronary artery bypass grafting (CABG) to sternal-sparing approaches, even in the robotic era. Automated coronary anastomotic connector technologies may address these difficulties, but to date, none have achieved broad adoption. Besides versatility, ease-of-use and cost-effectiveness, the key performance parameter of such technology is anastomotic patency. In this meta-analysis, we aim to evaluate published connector devices by examining their patency outcomes in distal anastomoses. Methods: The literature was systematically searched for studies comparing the angiographic patency of connector constructed coronary anastomoses to handsewn (HS) connections in adult patients undergoing CABG. The primary outcome was anastomosis patency across early (1 year) follow-up. Random-effects meta-analyses were employed to analyze and compare patency using pooled risk ratios (RR) with 95% confidence intervals (CI). Results: The search yielded 14 studies concerning eight connector devices. In 4,311 patients, a total of 4,328 anastomoses were constructed, 674 with connector devices and 3,654 with a HS technique. The pooled device patency over all timeframes was non-inferior to the HS technique (RR 0.90, 95% CI: 0.56–1.44). Technologies having a relatively large blood-exposed non-intimal surface area (BENIS, >15 mm2) performed acceptably when applied to large target vessels [>2.0–2.5 mm inner diameter (ID)]. A tiny anastomotic orifice area (AOA, < ca. 4 mm2) appeared to adversely affect results. Technologies realizing a generous AOA in combination with a limited BENIS showed superior results and applicability by performing well across the entire range of target coronary artery diameters (>1.0–1.5 mm ID). Conclusions: The overall results suggest that connectors yield at least non-inferior anastomosis patency outcomes compared to HS techniques in all observed timeframes. Optimizing device characteristics like BENIS and AOA appear fundamental for broad applicability.

1 December 2025 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
SHSam Heuts
Sam Heuts
PHPim van der Harst
Pim van der Harst
ENErika Nodin
Erika Nodin
JFJoakim Grant Frederiksen
Joakim Grant Frederiksen
PSPatrique Segers
Patrique Segers
WOWouter Oosterlinck
Wouter Oosterlinck

29 October 2024 in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Verified
Journal Article
Open access
MGMonica Gianoli
Monica Gianoli
AJAnne Roos de Jong
Anne Roos de Jong
HWHarmen Matthijs Wassink
Harmen Matthijs Wassink
PGPaul F. Gründeman
Paul F. Gründeman
BKBob Kiaii
Bob Kiaii
WSWillem J. L. Suyker
Willem J. L. Suyker
Objective: Totally endoscopic coronary artery bypass (TECAB) procedures pose significant challenges, motivating the development of Octocon, an automated endoscopic connector designed for coronary anastomoses in off-pump and endoscopic settings. This feasibility study aimed to assess Octocon’s functionality and maneuverability in closed-chest conditions during robot-assisted TECAB simulations. Methods: The Octocon deployment comprises a 3-step procedure. Initially, delicate self-aligning microstapling technology is used to attach connector halves to individual blood vessels. Subsequently, the connector halves are joined to accomplish the anastomosis process. TECAB conditions were simulated using a dedicated box housing ex vivo porcine hearts. The study, conducted by 3 experienced surgeons, investigated the feasibility and standardization potential of a robot-assisted procedure employing Octocon. It evaluated maneuverability in closed-chest conditions and assessed the effectiveness of grafting internal mammary artery segments to different heart regions using single graft, jump graft, and Y-graft constructions. Results: The robot-assisted procedure, using 4 standard instruments, successfully completed all 3 steps in 18 anastomotic procedures. In 96% of cases, the procedural steps were accomplished on the first attempt. The feasibility of constructing jump graft and Y-graft geometries on both anterior and posterior heart walls was demonstrated. Furthermore, experiences affirmed the device’s endoscopic user-friendliness, ease of teachability, reproducibility, and potential to achieve expedient, leak-free anastomoses. Conclusions: This ex vivo study confirmed Octocon’s potential suitability and functionality for TECAB. The device can create diverse grafting strategies and achieve wide-open vascular connections on various heart regions, highlighting its potential in advancing minimally invasive, robot-assisted coronary procedures. These promising results justify further exploration for integration into clinical practice.